- The EFPIA Code
- Codes of Conduct
- Clinical Trials
- Responsible Data Sharing
- About Efpia
The pharmaceutical industry recognises that it has a responsibility to show leadership in advancing responsible transparency. The industry supports measures that will enhance relationships between industry, healthcare practitioners, patients and citizens at large and advance public health.
"The Disclosure Code has been approved by the General Assembly on 24 June 2013. The final edited versions of the Code has been submitted to Compliance Committee comments, and has been reviewed by legal counsel.
On July 24, EFPIA and PhRMA formally launched their Joint Principles for Responsible Clinical Trial Data Sharing to Benefit Patients. This commitment to data sharing will enhance research and scientific knowledge, advance patient care and improve public health. Under the Principles, biopharmaceutical companies will dramatically increase the amount of information.read more